DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation
BIT:CPR • NL0015435975
Current stock price
5.936 EUR
-0.05 (-0.77%)
Last:
This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CPR.MI Profitability Analysis
1.1 Basic Checks
- In the past year CPR was profitable.
- CPR had a positive operating cash flow in the past year.
- CPR had positive earnings in each of the past 5 years.
- Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 4.27%, CPR is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
- With a Return On Equity value of 8.97%, CPR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- CPR has a better Return On Invested Capital (6.57%) than 66.67% of its industry peers.
- CPR had an Average Return On Invested Capital over the past 3 years of 6.98%. This is in line with the industry average of 7.47%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROIC | 6.57% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
1.3 Margins
- CPR has a better Profit Margin (11.35%) than 70.00% of its industry peers.
- In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
- CPR has a better Operating Margin (19.74%) than 70.00% of its industry peers.
- CPR's Operating Margin has improved in the last couple of years.
- With an excellent Gross Margin value of 60.31%, CPR belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
- In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% |
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
2. CPR.MI Health Analysis
2.1 Basic Checks
- CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for CPR has been reduced compared to 1 year ago.
- The number of shares outstanding for CPR has been increased compared to 5 years ago.
- The debt/assets ratio for CPR has been reduced compared to a year ago.
2.2 Solvency
- CPR has an Altman-Z score of 2.61. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
- CPR's Altman-Z score of 2.61 is fine compared to the rest of the industry. CPR outperforms 73.33% of its industry peers.
- The Debt to FCF ratio of CPR is 6.60, which is on the high side as it means it would take CPR, 6.60 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 6.60, CPR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
- A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
- CPR's Debt to Equity ratio of 0.59 is fine compared to the rest of the industry. CPR outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 2.61 |
ROIC/WACC0.99
WACC6.63%
2.3 Liquidity
- A Current Ratio of 2.22 indicates that CPR has no problem at all paying its short term obligations.
- CPR's Current ratio of 2.22 is amongst the best of the industry. CPR outperforms 83.33% of its industry peers.
- CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
- CPR's Quick ratio of 0.96 is amongst the best of the industry. CPR outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 |
3. CPR.MI Growth Analysis
3.1 Past
- CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
- Measured over the past years, CPR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.04% on average per year.
- The Revenue has decreased by -0.60% in the past year.
- The Revenue has been growing by 11.48% on average over the past years. This is quite good.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
3.2 Future
- Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.72% on average per year.
- Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 3.29% on average per year.
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CPR.MI Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 20.47, the valuation of CPR can be described as rather expensive.
- The rest of the industry has a similar Price/Earnings ratio as CPR.
- When comparing the Price/Earnings ratio of CPR to the average of the S&P500 Index (25.73), we can say CPR is valued slightly cheaper.
- The Price/Forward Earnings ratio is 18.32, which indicates a rather expensive current valuation of CPR.
- CPR's Price/Forward Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.72, CPR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.47 | ||
| Fwd PE | 18.32 |
4.2 Price Multiples
- CPR's Enterprise Value to EBITDA is on the same level as the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of CPR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.82 | ||
| EV/EBITDA | 12.25 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CPR has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as CPR's earnings are expected to grow with 13.95% in the coming years.
PEG (NY)2.85
PEG (5Y)1.7
EPS Next 2Y9.68%
EPS Next 3Y13.95%
5. CPR.MI Dividend Analysis
5.1 Amount
- CPR has a Yearly Dividend Yield of 1.62%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 2.74, CPR is paying slightly less dividend.
- Compared to an average S&P500 Dividend Yield of 1.91, CPR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.62% |
5.2 History
- The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 22.52% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP22.52%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
CPR.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:CPR (3/20/2026, 5:00:20 PM)
5.936
-0.05 (-0.77%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04 2026-03-04/amc
Earnings (Next)05-06 2026-05-06
Inst Owners21.32%
Inst Owner ChangeN/A
Ins Owners50.85%
Ins Owner ChangeN/A
Market Cap7.31B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts71.85
Price Target7.1 (19.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.62% |
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.47 | ||
| Fwd PE | 18.32 | ||
| P/S | 2.4 | ||
| P/FCF | 18.82 | ||
| P/OCF | 10.63 | ||
| P/B | 1.89 | ||
| P/tB | 18.42 | ||
| EV/EBITDA | 12.25 |
EPS(TTM)0.29
EY4.89%
EPS(NY)0.32
Fwd EY5.46%
FCF(TTM)0.32
FCFY5.31%
OCF(TTM)0.56
OCFY9.41%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)2.85
PEG (5Y)1.7
Graham Number4.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROCE | 8.89% | ||
| ROIC | 6.57% | ||
| ROICexc | 7.34% | ||
| ROICexgc | 17.16% | ||
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% | ||
| FCFM | 12.73% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 3.02 | ||
| Cap/Depr | 201.82% | ||
| Cap/Sales | 9.81% | ||
| Interest Coverage | 6.43 | ||
| Cash Conversion | 91.62% | ||
| Profit Quality | 112.13% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 2.61 |
F-Score8
WACC6.63%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year26.48%
EBIT Next 3Y15.06%
EBIT Next 5Y19.57%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%
DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.
What is the valuation status for CPR stock?
ChartMill assigns a valuation rating of 3 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.
Can you provide the financial health for CPR stock?
The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 6 / 10.
Can you provide the expected EPS growth for CPR stock?
The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 7.18% in the next year.